Because, COX-2 inhibition is at least part of the celecoxib's mechanism, these results propose that inhibition of COX-2 could have beneficial effects by altering the cascade of pathogenic processes in the experimental intracranial hemorrhage rat model (8). This evidence concerns the gene PTGS2 and intracranial hemorrhage.